Based on the pressârelease excerpt you provided, PomerantzâŻLLP has announced that it is investigating claims filed on behalf of NeoGenomics, Inc. (NASDAQ:âŻNEO) investors, and it is encouraging any affected shareholders to get in touch with the firm (DanielleâŻPeyton,âŻ[email protected],âŻ646â581â9980âŻext.âŻ7980).
However, the specific nature of the alleged wrongdoing is not disclosed in the portion of the news release that was shared. The announcement simply states that âPomerantz LLP is investigating claimsâ without detailing whether the claims involve, for example, alleged securitiesâfraud, misrepresentations, insiderâtrading, breach of fiduciary duty, false earnings statements, omitted material information, or any other particular misconduct.
In summary:
- Allegations being investigated: The press release says âclaimsâ from NeoGenomics investors are under investigation, but it does not specify what those claims allege.
- What is known: Pomerantz LLP is representing (or potentially representing) investors who believe they may have been harmed, and the firm is seeking additional investors to join the action.
- What is unknown: The exact allegations (e.g., fraud, misstatements, omitted disclosures, etc.) are not enumerated in the provided text.
If you need the precise allegations, you would need to obtain the full press release or a subsequent filing (e.g., a complaint, SEC filing, or detailed press statement) that outlines the investorsâ claims. Until such details are released publicly, the only concrete information available is that Pomerantz LLP is conducting an investigation on behalf of NeoGenomics investors.